Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Daniela Matuozzo; Estelle Talouarn; Astrid Marchal; Jeremy Manry; Yoann Seeleuthner; Yu Zhang; Alexandre Bolze; Matthieu Chaldebas; Baptiste Milisavljevic; Peng Zhang; Adrian Gervais; Paul Bastard; Takaki Asano; Lucy Bizien; Federica Barzaghi; Hassan Abolhassani; Ahmad Abou Tayoun; Alessandro Aiuti; Ilad Alavi Darazam; Luis Allende; Rebeca Alonso-Arias; Andres Augusto Arias; Gokhan Aytekin; Peter Bergman; Simone Bondesan; Yenan Bryceson; Ingrid Bustos; Oscar Cabrera-Marante; Sheila Carcel; Paola Carrera; Giorgio Casari; Khalil Chaibi; Roger Colobran; Antonio Condino-Neto; Laura Covill; Loubna El Zein; Carlos Flores; Peter Gregersen; Marta Gut; Filomeen Haerynck; Rabih Halwani; Selda Hancerli; Lennart Hammarstrom; Nevin Hatipoglu; Adem Karbuz; Sevgi Keles; Christele Kyheng; Rafael Leon-Lopez; Jose Luis Franco; Davood Mansouri; Javier Martinez-Picado; Ozge Metin Akcan; Isabelle Migeotte; Pierre-Emmanuel Morange; Guillaume Morelle; Andrea Martin-Nalda; Giuseppe Novelli; Antonio Novelli; Tayfun Ozcelik; Figen Palabiyik; Qiang Pan-Hammarstrom; Rebeca Perez de Diego; Laura Planas-Serra; Daniel Pleguezuelo; Carolina Prando; Aurora Pujol; Luis Felipe Reyes; Jacques Riviere; Carlos Rodriguez-Gallego; Julian Rojas; Patrizia Rovere-Querini; Agatha Schluter; Mohammad Shahrooei; Ali Sobh; Pere Soler-Palacin; Yacine Tandjaoui-Lambiotte; Imran Tipu; Cristina Tresoldi; Jesus Troya; Diederik van de Beek; Mayana Zatz; Pawel Zawadzki; Saleh Zaid Al-Muhsen; Hagit Baris-Feldman; Manish Butte; Stefan Constantinescu; Megan Cooper; Clifton Dalgard; Jacques Fellay; James Heath; Yu-Lung Lau; Richard Lifton; Tom Maniatis; Trine Mogensen; Horst von Bernuth; Alban Lermine; Michel Vidaud; Anne Boland; Jean-Francois Deleuze; Robert Nussbaum; Amanda Kahn-Kirby; France Mentre; Sarah Tubiana; Guy Gorochov; Florence Tubach; Pierre Hausfater; Isabelle Meyts; Shen-Ying Zhang; Anne Puel; Luigi Notarangelo; Stephanie Boisson-Dupuis; Helen Su; Bertrand Boisson; Emmanuelle Jouanguy; Jean-Laurent Casanova; Qian Zhang; Laurent Abel; Aurelie Cobat.
Preprint em Inglês | medRxiv | ID: ppmedrxiv-22281221

RESUMO

BackgroundWe previously reported inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity in 1-5% of unvaccinated patients with life-threatening COVID-19, and auto-antibodies against type I IFN in another 15-20% of cases. MethodsWe report here a genome-wide rare variant burden association analysis in 3,269 unvaccinated patients with life-threatening COVID-19 (1,301 previously reported and 1,968 new patients), and 1,373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. A quarter of the patients tested had antibodies against type I IFN (234 of 928) and were excluded from the analysis. ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI:1.5-528.7, P=1.1x10-4), in analyses restricted to biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70 [95%CI:1.3-8.2], P=2.1x10-4). Adding the recently reported TYK2 COVID-19 locus strengthened this enrichment, particularly under a recessive model (OR=19.65 [95%CI:2.1-2635.4]; P=3.4x10-3). When these 14 loci and TLR7 were considered, all individuals hemizygous (n=20) or homozygous (n=5) for pLOF or bLOF variants were patients (OR=39.19 [95%CI:5.2-5037.0], P=4.7x10-7), who also showed an enrichment in heterozygous variants (OR=2.36 [95%CI:1.0-5.9], P=0.02). Finally, the patients with pLOF or bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years; P=1.68x10-5). ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old.

2.
Rev. Asoc. Argent. Ortop. Traumatol ; 81(4): 281-286, 2016. ilus
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-835453

RESUMO

Introducción: Con las técnicas contemporáneas de reducción y osteosíntesis, la mayoría de las fracturas intertrocantéricas de cadera y de cuello femoral suelen consolidar sin problemas. La mayoría de estas fracturas se tratan mediante reducción cerrada y fijación interna con excelentes resultados. El fracaso terapéutico, por lo general, conduce a dolor y discapacidad funcional. En estos casos, los posibles tratamientos se reducen a dos, si se exceptúa el manejo conservador para pacientes críticos, una opción es una nueva osteosíntesis o la artroplastia total de cadera. La valguización de la falla de las fracturas tiene como objetivo transformar las fuerzas de cizallamiento de la zona de seudoartrosis en fuerzas compresivas, estimulando así la consolidación de las fracturas. Materiales y Métodos: Se evaluó retrospectivamente a 14 pacientes con seudoartrosis de fracturas intertrocantéricas de cadera, entre enero de 2010 y febrero de 2014, operados en nuestra institución. Todos fueron sometidos a una revisión con el objetivo de lograr una posición en valgo del fragmento proximal fijado siempre con clavo-placa de 95º (AO/ASIF). El objetivo de este estudio fue evaluar los resultados clínicos y radiológicos de seudoartrosis de fracturas intertrocantéricas de cadera. Resultados: Se logró la consolidación de la fractura en los 14 pacientes. El tiempo de consolidación promedio varió de tres a seis meses. El puntaje de Harris promedio para la valoración subjetiva fue de 82,65. En ningún caso, se extrajo el material luego de la consolidación de la fractura. Conclusión: El clavo-placa de 95º (AO/ASIF) sigue siendo una muy buena opción en los casos de seudoartrosis de fémur proximal, siempre que la planificación preoperatoria y la técnica quirúrgica sean correctas, y el posoperatorio sea adecuado.


Introduction: Contemporary techniques for reduction and internal fixation make most femoral neck and intertrochanteric hip fractures heal without problems. Most of these fractures are treated with closed reduction and internal fixation achieving excellent results. Treatment failure of hip fractures usually leads to pain and disability. Therapeutic alternatives can be limited to two options, with the exception of the conservative non-operative treatment in critical patients: a new fixation system or an arthroplasty. The valgus osteotomy aims to transform the shear forces in the area of nonunion into compressive forces, thereby stimulating fracture healing. Methods: Fourteen patients with intertrochanteric hip fracture nonunion were retrospectively evaluated between January 2010 and February 2014. All patients underwent revision surgery in order to achieve a valgus position of the proximal fragment, using a 95º blade plate (AO/ASIF). The objective of this study was to evaluate the clinical and radiographic results of intertrochanteric hip fracture nonunion treated with this method. Results: Fracture healing was achieved in all 14 patients. Average healing time ranged from three to six months. The Harris score averaged 82.65. Hardware removal was not performed after fracture healing. Conclusion: The 95° blade plate is still a very good option in cases of proximal femur nonunion, provided the preoperative planning and the surgical technique are correct and the postoperative care is adequate.


Assuntos
Humanos , Pinos Ortopédicos , Fêmur , Fraturas do Quadril/cirurgia , Placas Ósseas , Pseudoartrose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...